New Day Diagnostics

05/30/2026

A major milestone in colorectal cancer prevention: the American Cancer Society has updated its screening guidelines to include blood-based screening for the first time ever. 👏

At ColoHealth, we applaud this important step forward. More screening options mean more people getting screened — and more lives saved through early detection.

What makes ColoHealth Direct unique?

ColoHealth Direct is designed to go beyond cancer detection by helping identify precancerous polyps earlier — before cancer develops. Based on FDA clinical trial data and peer-reviewed studies, ColoHealth Direct has demonstrated stronger detection of advanced precancerous lesions than currently available blood-based colorectal cancer screening tests.

Why does that matter? Because finding and removing precancerous polyps can help stop colorectal cancer before it starts.

The message remains simple: screening saves lives. If you’re age 45+ — or younger with family history or risk factors — now is the time to get screened.

Read the American Cancer Society announcement: https://zurl.co/H178h

ATLANTA, May 27, 2026 — The American Cancer Society (ACS) today released updated guidelines for colorectal cancer screening. The new recommendations reaffirm that average-risk adults should...

05/29/2026

Colorectal cancer is rising in younger adults. Don’t ignore the signs.

05/28/2026

Need help validating your diagnostic test? Let’s get it done.

Developing a new assay and need support with analytical and clinical performance validation? New Day Diagnostics is here to partner with you every step of the way.

From protocol design to study ex*****on, our team ensures your validation is scientifically rigorous and aligned with regulatory expectations. We provide comprehensive support for both 510(k) submissions and Laboratory Developed Test (LDT) / CLIA validation requirements.

With our CLIA-certified, ISO 13485-compliant laboratory, we generate high-quality data to help you move confidently toward regulatory submission, clinical implementation, and commercialization.

05/27/2026

A major milestone in colorectal cancer prevention: the American Cancer Society has updated its screening guidelines to include blood-based screening for the first time ever. 👏

At ColoHealth, we applaud this important step forward. More screening options mean more people getting screened — and more lives saved through early detection.

What makes ColoHealth Direct unique?

ColoHealth Direct is designed to go beyond cancer detection by helping identify precancerous polyps earlier — before cancer develops. Based on FDA clinical trial data and peer-reviewed studies, ColoHealth Direct has demonstrated stronger detection of advanced precancerous lesions than currently available blood-based colorectal cancer screening tests.

Why does that matter? Because finding and removing precancerous polyps can help stop colorectal cancer before it starts.

The message remains simple: screening saves lives. If you’re age 45+ — or younger with family history or risk factors — now is the time to get screened.

Read the American Cancer Society announcement: https://zurl.co/kMUy9

ATLANTA, May 27, 2026 — The American Cancer Society (ACS) today released updated guidelines for colorectal cancer screening. The new recommendations reaffirm that average-risk adults should...

05/26/2026

Colorectal cancer is no longer just a disease affecting older adults.

Rates among people under 50 have been rising steadily—often diagnosed at later stages because symptoms are overlooked.

Know the warning signs:
• Persistent abdominal discomfort
• Changes in bowel habits
• Blood in stool

If something feels off, don’t ignore it. Early detection can make all the difference.